Erratum to: Tolerability of High-Volume Subcutaneous Injections of a Viscous Placebo Buffer: A Randomized, Crossover Study in Healthy Subjects

Clapton Dias¹, Bassam Abosaleem², Caroline Crispino², Bing Gao^{2

3}, Adam Shaywitz^{2

4}

Affiliations

¹ Amgen Inc., 1 Amgen Center Drive, Thousand Oaks, CA, 91320, USA. claptondias@gmail.com.
² Amgen Inc., 1 Amgen Center Drive, Thousand Oaks, CA, 91320, USA.
³ Gilead Sciences, Foster City, CA, USA.
⁴ BioMarin Pharmaceutical, Inc., San Rafael, CA, USA.

Published Erratum

Clapton Dias et al. AAPS PharmSciTech. 2015 Dec.

. 2015 Dec;16(6):1500.

doi: 10.1208/s12249-015-0324-y.

Clapton Dias¹, Bassam Abosaleem², Caroline Crispino², Bing Gao^{2

3}, Adam Shaywitz^{2

4}

¹ Amgen Inc., 1 Amgen Center Drive, Thousand Oaks, CA, 91320, USA. claptondias@gmail.com.
² Amgen Inc., 1 Amgen Center Drive, Thousand Oaks, CA, 91320, USA.
³ Gilead Sciences, Foster City, CA, USA.
⁴ BioMarin Pharmaceutical, Inc., San Rafael, CA, USA.

No abstract available

Erratum for

Tolerability of High-Volume Subcutaneous Injections of a Viscous Placebo Buffer: A Randomized, Crossover Study in Healthy Subjects.
Dias C, Abosaleem B, Crispino C, Gao B, Shaywitz A. Dias C, et al. AAPS PharmSciTech. 2015 Oct;16(5):1101-7. doi: 10.1208/s12249-015-0288-y. Epub 2015 Feb 19. AAPS PharmSciTech. 2015. PMID: 25693652 Free PMC article. Clinical Trial.